Hims retreats from weight loss pill launch as Novo, FDA pressure mounts
Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new oral weight loss medicine. But the reaction to the move has caused the company to quickly retreat.